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Abstract 
Ameloblastoma, a benign neoplasm of jaw bones is the most common of all odontogenic tumors. Its pathology 
is generally well understood and is easy to diagnose. This article presents a rare case of an ameloblastoma with 
atypical features depicting an example of the diagnostic difficulty posed by some ameloblastomas and briefly re-
views the classification and literature of odontogenic malignancies. This case is unusual in the fact that although 
the clinical presentation was suggestive of a malignancy, the histological features were not sufficient to warrant the 
lesion as malignant. Albeit, the features of epithelial dedifferentiation were evident at post operative histopatholo-
gical evaluation but no proof was available to authenticate frank metastasis or carcinoma. The case was diagnosed 
as an atypical ameloblastoma and frequent follow up was recommended. This article discusses about ameloblastic 
carcinoma, other odontogenic malignancies and emphasizes the need for standardization and quantification of the 
fundamental concepts of odontogenic malignancies for more reliable and early diagnosis for better treatment and 
prognosis.
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Introduction
Of all the odontogenic tumors, the pathology of ame-
loblastoma – being the most common is generally well 
understood. However the concept of odontogenic ma-
lignancies has been a subject of considerable discussion 
and controversy for many years. The term ameloblastic 
carcinoma is used to designate a lesion with histological 
evidence of malignancy in primary tumor, regardless of 
whether it has metastasized (1). The malignant epithelial 
proliferation may initially be present with a resemblance 
to an ameloblastoma (de novo ameloblastic carcinoma) 
or sometimes an ameloblastoma may show features of 
epithelial dedifferentiation overtime (ameloblastic car-
cinoma ex-ameloblastoma) (2). If the anaplastic fea-
tures are not sufficient to justify an ameloblastoma as 
malignant, it can be called as atypical ameloblastoma 
(3).  Ameloblastic carcinoma is a rare odontogenic ma-
lignancy that challenges the diagnostic acumen of the 
pathologists as the understanding of the identifying his-
tological features of the tumor is some what vague and 
not standardized/quantified. We herein report a rare case 
of ameloblastoma which had an aggressive behavior 
and histologically had areas of cytological atypia which 
warrant a more aggressive surgical approach and follow 
up. The purpose of this article is to emphasize the need 
for standardization and quantification of the fundamen-
tal concepts of odontogenic malignancies for more relia-
ble and early diagnosis because this has a direct bearing 
on the treatment plan and prognosis.
Case Report
A 58 years old male patient reported to the out patient 
department of Manipal college of dental sciences, Man-
galore in February 2007 with the chief complaint of a 
non tender swelling of 2 years duration on the left side of 
his face. The swelling had started as a small peanut size 
bulge and had gradually increased to the present size. 
The patient gave no history of fever, malaise, associated 
pain or parasthesia or dysphagia. The past medical his-
tory revealed that an incisional biopsy had been perfor-
med previously which was suggestive of ameloblastoma. 
Family history was non contributory and social history 
disclosed a chronic alcoholic with a habit of chewing 
tobacco with betel quid for past 20 years.
Clinically, patient had a medium built and was poorly 
nourished, conscious and cooperative. On local exami-
nation, a diffuse swelling of size 2×3 cm was present 
extraorally on the left side of face corresponding to the 
angle of mandible. The swelling was non tender, firm in 
consistency and had a smooth texture. Intraoral exami-
nation revealed an unhealed extraction socket in relation 
to 37 and expansion of buccal and lingual cortical plates. 
There was no dysphagia, pain or paresthesia.
The teeth present in the area showed no mobility or 
loosening. Left submandibular lymph nodes were pal-
pable and tender. Radiographic examination of the man-
dible revealed a multilocular destructive lesion in 37, 38 
region involving the body and ramus of mandible and 36 
showed root resorption. The chest radiographs did not 
demonstrate pulmonary lesions and hematological and 
biochemical investigations were unremarkable. Ultra-
sound revealed a fatty liver.
Based on the above findings, a diagnosis of ameloblas-
toma was made and patient underwent a hemimandibu-
lectomy procedure and submandibular glands were also 
removed. The excised tissue was sent for further histo-
pathological evaluation. Postoperative recovery was 
uneventful and patient was advised a follow up exami-
nation after 3 months.
The excisional tissue grossly showed a large swelling 
extending from 36 to the angle of mandible. The buccal 
side showed a large cystic cavity where as the lingual 
aspect showed a solid proliferation of the tumor mass 
showing necrotic area in centre. The occlusal aspect 
showed 33, 34, 35, 36 and an ulcerated area posterior to 
36 (unhealed extraction socket) (Fig. 1).
Fig. 1. Gross appearances of the specimen from occlusal view 
showing expansion of the buccal and lingual cortical plates with 
unhealed socket in relation to 37
Microscopically, the tissue sections from the buccal as-
pect showed a characteristic lining suggestive of a uni-
cystic ameloblastoma consisting of a basal layer of tall 
columnar ameloblast like cells exhibiting reversal of po-
larity. The superficial layers consist of several rows of 
stellate reticulum like cells. Focal areas of lining epithe-
lium showed flattened basal cells. Proliferations of the 
lining epithelium into the lumen as well as underlying 
connective tissue were also observed. The mural as well 
as the luminal proliferations showed plexiform amelo-
blastoma with areas of microcyst formation arising as a 
result of stromal degeneration. The stromal blood vessels 
showed degenerative changes appearing only as ghostly 
outlines surrounding few inflammatory cells.
The sections from the unhealed socket area revealed ul-
cerated parakeratinised stratified squamous epithelium 
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with epithelial proliferation noted at the margin of ulcer. 
Deeper in the connective tissue the epithelial prolifera-
tion from the margin of ulcer merged with the plexiform 
ameloblastoma. 
The sections taken from the lingual aspect revealed a 
follicular ameloblastoma showing numerous small and 
large sized ameloblastomatous follicules with a central 
core of stellate reticulum like cells and areas of cystic 
degeneration. Sheets of odontogenic epithelial cells wi-
thin the connective tissue demonstrated extensive ce-
llular pleomorphism with cells varying from ovoid to 
spindle in shape (Fig. 2). Occasional mitosis (typical 
and atypical) was evident within the sheets of odontoge-
nic epithelium along with other features like increased 
nuclear cytoplasmic ratio, prominent nucleoli (Fig. 2). 
However, the epithelial dedifferentiation as seen in the 
present case, is not enough to warrant the ameloblasto-
ma as malignant. Such tumors can be called as atypical 
ameloblastoma (3). 
Ameloblastic carcinoma is a malignant odontogenic tu-
mor, the diagnosis of which is as enigmatic, as was its 
position in the classification of odontogenic malignan-
cies. The term Ameloblastic carcinoma was acknowled-
ged by the World Health Organization (WHO) (2) as late 
as in 2002. The classification of odontogenic malignan-
cies and the concept of malignancy in ameloblastoma is 
a controversial topic which has been discussed for long. 
Various classifications have been developed to categori-
ze ameloblastic carcinomas (2-5). 
The WHO published its classification for malignant 
neoplasms and other tumors related to the odontogenic 
apparatus in 1972 and recognized the following subty-
pes:
Odontogenic carcinoma
  A. Malignant ameloblastoma
  B. Primary intraosseous carcinoma (PIOC)
  C. Other carcinoma arising from odontogenic epithe-
lium including those arising from odontogenic cyst
In this initial attempt to classify odontogenic carcinomas, 
the WHO failed to specifically delineate ameloblastic 
carcinomas. This WHO classification system recognized 
and distinguished PIOC from malignant ameloblastoma 
but it did not consider the possibility that a squamous 
cell carcinoma could arise in a pre-existing ameloblas-
toma and had no sub-division under which such entities 
could be placed. 
Initially, the term ameloblastic carcinoma was introdu-
ced to describe ameloblastomas in which there had been 
histological malignant transformation in association 
with less differentiated evidence of metastatic growths. 
Such tumors showed features of ameloblastoma inter-
mingled with those of carcinoma. 
Elzay (4) in 1982 suggested that the WHO classification 
Fig. 2. Dysplastic cells exhibiting occasional atypical mitoses with 
cellular pleomorphism 
In addition, dominant areas on lingual aspect showed 
sheets of squamoid cells exhibiting dyskeratosis with 
interspersed areas of extensive hemorrhage, degene-
ration and necrosis (Fig. 3). Few multinucleated giant 
cells were also evident. The submandibular nodes were 
completely free of tumor. Based on the above findings a 
diagnosis of atypical ameloblastoma was given. 
Discussion
The typical ameloblastoma is a histologically benign tu-
mor but it has considerable tendency to recur and even 
cause death by invasion of vital structures. Although it 
is locally invasive, it rarely shows metastatic dissemi-
nation. In a malignant ameloblastoma both the primary 
as well as the metastatic deposits has the typical histo-
logical features of ameloblastoma. On the other hand, 
histological evidences of malignancy in the primary or 
recurrent tumor, regardless of whether it has metasta-
sized, characterize it as an ameloblastic carcinoma (1). 
Fig. 3. Areas of degeneration,hemorrhage and necrosis
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be modified to permit the separation and recognition of 
closely related entities. So he classified all intraosseous 
carcinoma under the heading of PIOC and then those tu-
mors were subclassified and subtyped according to his-
tological evidence of origin. The proposed classification 
was as follows:
Primary Intraosseous Carcinoma
Type 1 – Arising ex odontogenic cyst 
Type 2 – Arising ex ameloblastoma
         a)  Well differentiated - Malignant ameloblastoma
         b)  Poorly differentiated - Ameloblastic carcinoma
Type 3 – Arising de novo
         a)  Non-keratinizing
         b)  Keratinizing
Accordingly, the PIOC type II recognized the potential 
for malignification of ameloblastoma with varing degree 
of differentiation. Hence II A was reserved for tumors 
which histologically demonstrated proper ameloblasto-
ma in the jaw and in any metastatic lesion. In essence, 
such tumors would be well differentiated where as the 
type II B sub classification was reserved for less diffe-
rentiated tumors having histological features of amelo-
blastoma and squamous cell carcinoma concomitantaly.
Two years later, in 1984, Slootweg and Müller (5) pu-
blished a paper reviewing 42 cases of malignant ame-
loblastoma (according to WHO) and adding 2 more to 
the list. They pointed out that some cases of PIOC may 
have areas that are morphologically similar to malignant 
ameloblastoma. Thus there is a possibility that a PIOC 
would have been classified as a malignant ameloblasto-
ma if metastasis had occurred or as a PIOC if metastasis 
had not occurred. They also pointed out that matters had 
been further complicated because of no distinction bet-
ween malignant ameloblastoma and ameloblastic carci-
noma. They said that the WHO classification of odon-
togenic carcinoma should be revised in some aspects. 
They advocated the modification proposed by Elzay (4) 
and proposed a slight modification taking in account the 
various possible origins of PIOC. So the classification 
they proposed was:
Primary Intraosseous Carcinoma
Type 1 – Primary intraosseous carcinoma ex odontoge-
nic cyst
Type 2 – Primary intraosseous carcinoma arising ex 
ameloblastoma
     a)  Malignant ameloblastoma
     b)  Ameloblastic carcinoma, arising de novo, ex ame-
loblastoma or odontogenic cyst 
Type 3 – Primary intraosseous carcinoma arising de 
novo
     a)  Non-keratinizing
     b)  Keratinizing 
So, they accepted that malignant ameloblastoma and 
ameloblastic carcinoma be included under the encom-
passing term “PIOC ex ameloblastoma” as proposed by 
Elzay (4). And they proposed that for giving a correct 
diagnosis, the taxonomic problem can be avoided by as-
suming that ameloblastic carcinomas can arise not only 
de novo or from a well differentiated ameloblastoma but 
also from other sources of odontogenic epithelium eg. 
odontogenic cyst. Thus, the main difference between 
Elzay’s (4), and Slootweg and Müller’s (5) schemes re-
lates to the minor point of histogenesis. 
In 1992, a modified WHO classification system for the 
odontogenic carcinomas was published (7), including 
the following categories:
Odontogenic carcinoma
       A.   Malignant ameloblastoma
       B.   Primary intraosseous carcinoma
       (de novo, ex ameloblastoma, ex odontogenic cyst)
       C.   Malignant variants of other odontogenic epithe-
lial tumors  
       D.   Malignant changes in odontogenic cyst
Inspite of all the proposals made, it failed to recognize 
ameloblastic carcinoma as a separate entity. Since the 
WHO classification did not recognize the existence of 
ameloblastic carcinoma, all such lesions had to be clas-
sified either as PIOC or as malignant ameloblastoma. 
Because of this overlapping of terminologies, the po-
tential of the histological diagnosis to distinguish the 
biologic behavior, prognosis and treatment plan of the 
ameloblastic carcinoma and closely related tumors was 
hindered. This taxonomic problem continued for a de-
cade and finally ended in 2002 when ameloblastic carci-
noma was recognized by the WHO in its revised version 
by Philipsen and Reichart (2). 
The categories identified in the WHO’s revised version 
2002 (2) were:
Odontogenic carcinoma
     A.   Metastasizing ameloblastoma
     B.   Ameloblastic carcinoma
                *  Primary (=de novo)
                *  Carcinoma ex ameloblastoma (=dedifferen-
tiated)
                *  Peripheral
     C.   Primary intraosseous carcinoma
                *  Solid
                *  Cystogenic 
     D.   Ghost cell odontogenic carcinoma
     E.   Clear cell odontogenic carcinoma
Thus, the term “ameloblastic carcinoma” was used by 
Shafer, Elzay(4), Slootweg and Müller’s (5), primarily 
to convey the presence of cytologic features of malig-
nancy in an ameloblastoma came into being and got re-
cognized. 
Ameloblastic carcinoma is considered to be a rare odon-
togenic malignancy. Akrish et al. (6) analyzed all the 
published cases in English language literature between 
the years 1984 and 2004 to find only 37 cases reported 
in addition to the case presented in the paper (making a 
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total of 38 cases). It might be that, because of the pro-
longed controversy around ameloblastic carcinoma it 
was either wrongly categorized or less reported. Unfor-
tunately, as a consequence of this, the understanding of 
the identifying clinical and histological features of the 
tumor is still some what vague and not standardized/
quantified.
Although Corio et al. (1) had reported the mean age of 
occurrence to be 30.1 years with no gender predilec-
tion, recently Akrish et al. (6) reported the mean age of 
occurrence to be 52 years and the male to female ratio 
being 1.5 to 1. The posterior mandible was the most fa-
vored site in both the reports. Radiographically the tu-
mor resembles ameloblastoma and mostly appears as a 
multilocular radiolucency. Clinically the patients mostly 
complain of expansion, a hard mass, rapid growth, fa-
cial asymmetry, a nonhealing extraction site, an ulcer, 
a fistula or perforation of the cortex. These clinical fea-
tures though suggestive of a malignancy, are again not 
pathognomonic. In the present case also the patient had 
most of these features. 
Histologically ameloblastic carcinoma demonstrates 
more cytologic atypia and mitotic activity than ame-
loblastoma. It includes the features of epithelial dedi-
fferentiation. There is lack of evidence of reverse po-
larization, sheets of disordered mitotically active small 
basaloid cells with dark nuclei; larger squamoid or po-
lygonal cells with vesicular nuclei; or elongated spin-
dled epithelial cells (6). The histological diagnosis is not 
an easy one and a pathologist must rule out a lexicon of 
differential diagnosis which includes the typical amelo-
blastoma, metastatic carcinoma to the jaw, intra bony ex-
tension of a surface mucosal carcinoma, central salivary 
gland tumor, PIOC, acanthomatous ameloblastoma, ke-
ratoameloblastoma, squamous odontogenic tumor, and 
calcifying epithelial odontogenic tumor. In the present 
case also all these differential diagnoses were ruled out 
as elaborated by Coiro et al. (1)
Until 2004, the terms aggressive or proliferative ame-
loblastoma, ameloblastic carcinoma and atypical 
ameloblastoma were used synonymously by some in-
vestigators (7). In 2004 Slater (3) suggested that  ame-
loblastomas which exhibit basilar hyperplasia and an in-
creased mitotic index should be designated as “atypical 
ameloblastomas” or “proliferative ameloblastomas” be-
cause these findings are probably insufficient to permit 
a diagnosis of ameloblastic carcinoma in the absence of 
nuclear pleomorphism, perineural invasion or other his-
tologic evidence of malignancies (3). The picture is fur-
ther complicated by the fact that although the presence 
of abundant mitotic figures is one of the most important 
diagnostic criteria, the prognostic significance of this is 
not known (8). 
The enigma about the diagnosis of ameloblastic carcino-
ma is further aggravated because the diagnostic criteria 
to distinguish between ameloblastoma, atypical amelo-
blastoma and ameloblastic carcinoma are not standar-
dized/ quantified. Many important questions/concepts 
remain unanswered e.g.  Is the diagnosis of atypical 
ameloblastoma of any relevance for treatment options? 
What features are necessary to differentiate between the-
se closely related lesions? Which histologic feature is 
a sine qua non for diagnosing a particular odontogenic 
malignancy? If two lesions have an overlapping features 
e.g. Presence of mitotic figures or a high proliferative in-
dex, how many mitoses per high power field or what per-
cent of cells showing high index should distinguish two 
closely related lesions? We hereby strongly propose that 
the fundamental concepts of odontogenic malignancies 
should be standardized and quantified for more reliable 
and early diagnosis because this has a direct bearing on 
the treatment plan and prognosis. 
To conclude, the present case is an example of the diag-
nostic difficulty posed by some ameloblastomas. This 
case is unusual in the fact that although the age, rapidity 
of growth and clinical presentation were suggestive of a 
malignancy, the histological features were not sufficient 
to warrant the lesion as malignant. Albeit, the features of 
epithelial dedifferentiation were evident at post operative 
histopathological evaluation but no proof was available 
to authenticate frank metastasis or carcinoma. Hence in 
the light of current concepts the tumor was categorized 
as an ameloblastoma with atypical features and frequent 
follow up was recommended.   
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